Niemann Pick disease type C (NPC) is an autosomal recessive lipidosis that is characterized by lysosomal storage of cholesterol and glycosphingolipids. NPC patients suffer from cholestasis, prolonged jaundice, and hepatosplenomegaly. The mechanism by which NPC1 protein dysfunction leads to liver disease is unknown. We have developed a unique mouse model with which to study NPC1 liver disease. Treatment of mice with a NPC1 specific antisense oligonucleotide leads to liver specific and reversible knockdown of NPC1 protein expression. Our goal is to determine the mechanism by which lysosomal lipid storage leads to liver disease. Our hypothesis is that NPC liver disease is initiated by the massive lipid storage, which leads to lysosome destabilization and release of pro-apoptotic proteases and lipids. Hepatocyte apoptosis is then propagated through the TNFa pathway. We expect that if NPC1 were re-expressed in the knockdown mouse, then the fibrotic liver would recover. Because our model of NPC1 knockdown is reversible, we have the ability to study disease regression.
Specific Aim #1 - To determine if the lysosomal lipid storage in NPC mouse hepatocytes leads to rupture of lysosomes and release of their contents to activate apoptosis. Our preliminary results suggest that NPC1 knockdown leads to release of cathepsins from lysosomes. We will determine if cathepsin knockdown reduces NPC hepatocyte apoptosis.
Specific Aim #2 - To determine if NPC liver disease is propagated through the TNFa pathway. Our preliminary results indicate that NPC1 knockdown in TNFa-deficient mice leads to a less severe disease phenotype. We will test this hypothesis using TNF1 knockout mice, liver- specific knockdown of the TNFa-receptor, TNF-RI, and an inhibitor of the TNFa pathway.
Specific Aim #3 - To determine the course of reversal of NPC liver disease upon re-expression of the NPC1 protein in the NPC1 knockdown mouse model. Our preliminary results indicate that NPC1 re-expression leads to reduced liver injury and inflammation. We will determine the extent to which NPC1 re-expression fully reverses the hepatic disease phenotype.

Public Health Relevance

Our studies will identify the signals that initiate and propagate Niemann-Pick C liver disease, providing information that is critical for designing therapeutic strategies. We will also determine the extent to which NPC liver disease can be reversed in order to achieve maximal benefit from an NPC therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049564-18
Application #
8255586
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Sherker, Averell H
Project Start
1995-05-01
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2014-04-30
Support Year
18
Fiscal Year
2012
Total Cost
$417,622
Indirect Cost
$164,518
Name
Tufts University
Department
Physiology
Type
Schools of Medicine
DUNS #
039318308
City
Boston
State
MA
Country
United States
Zip Code
02111
Sayre, Naomi L; Rimkunas, Victoria M; Graham, Mark J et al. (2010) Recovery from liver disease in a Niemann-Pick type C mouse model. J Lipid Res 51:2372-83
Vincent, Melanie; Sayre, Naomi L; Graham, Mark J et al. (2010) Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann-Pick C liver disease. PLoS One 5:e12941
Rimkunas, Victoria M; Graham, Mark J; Crooke, Rosanne M et al. (2009) TNF-{alpha} plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease. J Lipid Res 50:327-33
Rimkunas, Victoria M; Graham, Mark J; Crooke, Rosanne M et al. (2008) In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease. Hepatology 47:1504-12
Passeggio, Jessica; Liscum, Laura (2005) Flux of fatty acids through NPC1 lysosomes. J Biol Chem 280:10333-9
Liscum, Laura; Sturley, Stephen L (2004) Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport. Biochim Biophys Acta 1685:22-7
Wojtanik, Kari M; Liscum, Laura (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 278:14850-6
Munn, Natalie J; Arnio, Emily; Liu, Dailan et al. (2003) Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. J Lipid Res 44:182-92
Liscum, Laura; Arnio, Emily; Anthony, Monique et al. (2002) Identification of a pharmaceutical compound that partially corrects the Niemann-Pick C phenotype in cultured cells. J Lipid Res 43:1708-17
Underwood, K W; Jacobs, N L; Howley, A et al. (1998) Evidence for a cholesterol transport pathway from lysosomes to endoplasmic reticulum that is independent of the plasma membrane. J Biol Chem 273:4266-74

Showing the most recent 10 out of 11 publications